Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?

Brady L. Stein*, Srdan Verstovsek

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)507-509
Number of pages3
JournalCurrent Hematologic Malignancy Reports
Issue number6
StatePublished - Dec 1 2017


  • Myeloproliferative neoplasm
  • Polycythemia vera
  • Prognosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this